Files

Download

Download Full Text (1.7 MB)

Keywords

protective effects against Alzheimers, inflammation

Abstract

Alzheimer’s Disease (AD) is a fatal neurodegenerative condition that is the leading cause of dementia among elderly patients. It is commonly associated with neuroinflammation and its progression is evident in higher levels of serum chemokines and activated microglia. We have identified a receptor and its mutant, CCRL2-V180M, associated with lower levels of the pro-inflammatory chemokine ligand, CCL4. We have previously identified ligand binding behaviorof one isoform of CCRL2, CRAM-A and propose to compare its behaviour to the more commonly expressed isoform, CRAM-B. We hypothesize that CCRL2-V180M binds with a higher affinity than WT to CCL4, decreasing levels of CCL4 in the CSF and offering possible protection against AD.

Document Type

Poster

Publication Date

2020-04-03

Language

English

College

Life Sciences

Department

Microbiology and Molecular Biology

University Standing at Time of Publication

Junior

Chemokine Receptor CCRL2-V180M and Its Role in Inflammation and Alzheimer's Disease

Included in

Life Sciences Commons

Share

COinS